Sungui Wu

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Nanjing University of Chinese Medicine(Current)

Nanjing Drum Tower Hospital

Sungui Wu is an author at Nanjing University of Chinese Medicine specializing in phosphoinositide 3-kinase signaling, cancer immunology, and immunotherapy.

ORCID

Publications per year

2022–2024

Publications

Formosanin C induces autophagy-mediated apoptosis in multiple myeloma cells through the PI3K/AKT/mTOR signaling pathway

Ping Chen, Sungui Wu, Xiaoqing Dong et al. · Hematology · 2022 · 11 citations · Full text

Life Sciences, Cell Biology, Pharmacology +17

Development of novel humanized <scp>CD19</scp>/<scp>BAFFR</scp> bicistronic chimeric antigen receptor T cells with potent antitumor activity against B‐cell lineage neoplasms

Sungui Wu, Qian Luo, Feiyu Li et al. · British Journal of Haematology · 2024 · 11 citations

Life Sciences, Immunology, Oncology +17

1–2 of 2